EKF Diagnostics Holdings Plc (EKF) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.068x

Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has a cash flow conversion efficiency ratio of 0.068x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.79 Million ≈ $582.44 USD) by net assets (GBX70.28 Million ≈ $8.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EKF Diagnostics Holdings Plc (EKF) total market value for the company's overall valuation and market capitalisation.

EKF Diagnostics Holdings Plc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how EKF Diagnostics Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EKF Diagnostics Holdings Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their cash flow conversion efficiency. Explore EKF Diagnostics Holdings Plc (EKF) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
MT Educare Limited
NSE:MTEDUCARE
-0.429x
Osteopore Ltd
AU:OSX
0.739x
Future Supply Chain Solutions Limited
NSE:FSC
0.108x
Usha Martin Education & Solutions Limited
NSE:UMESLTD
0.019x
ProAm Explorations Corp
V:PMX
0.370x
Golden Prospect Precious Metals Ltd
LSE:GPM
-0.016x
Invinity Energy Systems PLC
LSE:IES
-0.083x
VULTUS AB
F:V06
0.733x

Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings Plc (2001–2025)

The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2025. View EKF Diagnostics Holdings Plc stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX70.28 Million
≈ $8.55K
GBX9.71 Million
≈ $1.18K
0.138x -25.95%
2024-12-31 GBX73.21 Million
≈ $8.91K
GBX13.66 Million
≈ $1.66K
0.187x +101.62%
2023-12-31 GBX68.22 Million
≈ $8.30K
GBX6.31 Million
≈ $767.87
0.093x -28.84%
2022-12-31 GBX74.52 Million
≈ $9.07K
GBX9.69 Million
≈ $1.18K
0.130x +20.30%
2021-12-31 GBX94.74 Million
≈ $11.53K
GBX10.24 Million
≈ $1.25K
0.108x -38.80%
2020-12-31 GBX78.20 Million
≈ $9.51K
GBX13.81 Million
≈ $1.68K
0.177x +146.43%
2019-12-31 GBX71.17 Million
≈ $8.66K
GBX5.10 Million
≈ $620.52
0.072x -44.98%
2018-12-31 GBX63.90 Million
≈ $7.78K
GBX8.32 Million
≈ $1.01K
0.130x -12.96%
2017-12-31 GBX60.50 Million
≈ $7.36K
GBX9.05 Million
≈ $1.10K
0.150x +2.02%
2016-12-31 GBX60.97 Million
≈ $7.42K
GBX8.94 Million
≈ $1.09K
0.147x +260.04%
2015-12-31 GBX46.75 Million
≈ $5.69K
GBX-4.29 Million
≈ $-521.36
-0.092x -68.80%
2014-12-31 GBX87.38 Million
≈ $10.63K
GBX-4.74 Million
≈ $-577.21
-0.054x -210.70%
2013-12-31 GBX40.92 Million
≈ $4.98K
GBX2.01 Million
≈ $244.19
0.049x +20.93%
2012-12-31 GBX39.43 Million
≈ $4.80K
GBX1.60 Million
≈ $194.55
0.041x +288.32%
2011-12-31 GBX37.43 Million
≈ $4.55K
GBX-806.00K
≈ $-98.07
-0.022x +64.04%
2010-12-31 GBX23.53 Million
≈ $2.86K
GBX-1.41 Million
≈ $-171.43
-0.060x +50.22%
2009-12-31 GBX5.62 Million
≈ $683.79
GBX-676.00K
≈ $-82.25
-0.120x +5.74%
2008-12-31 GBX5.07 Million
≈ $616.87
GBX-647.00K
≈ $-78.72
-0.128x -210.05%
2007-12-31 GBX4.98 Million
≈ $605.44
GBX577.00K
≈ $70.20
0.116x +160.35%
2006-12-31 GBX4.30 Million
≈ $523.06
GBX-826.00K
≈ $-100.50
-0.192x -3668.00%
2005-12-31 GBX3.71 Million
≈ $451.89
GBX20.00K
≈ $2.43
0.005x +101.97%
2004-12-31 GBX3.12 Million
≈ $379.01
GBX-852.00K
≈ $-103.66
-0.274x -2390.00%
2003-12-31 GBX2.46 Million
≈ $299.07
GBX-27.00K
≈ $-3.29
-0.011x -498.46%
2002-12-31 GBX2.90 Million
≈ $353.09
GBX8.00K
≈ $0.97
0.003x -99.58%
2001-12-31 GBX214.00K
≈ $26.04
GBX142.00K
≈ $17.28
0.664x --

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.30 Million
GBX10.70 Billion GBX
Market Cap Rank
#30506 Global
#765 in UK
Share Price
GBX25.00
Change (1 day)
+0.00%
52-Week Range
GBX21.80 - GBX31.00
All Time High
GBX78.21
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more